Literature DB >> 26953036

Vogt-Koyanagi-Harada Syndrome following influenza vaccination.

Moosang Kim1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26953036      PMCID: PMC4821134          DOI: 10.4103/0301-4738.178141

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Sir, Uveitis is a rare adverse event of vaccination with a low incidence rate as about 10.5 per 100,000.[1] Vogt-Koyanagi-Harada Syndrome is a very rare adverse event of vaccination, and there is only one case report in worldwide.[2] We recently experienced a case of Vogt-Koyanagi-Harada Syndrome following vaccination of influenza, thus herein report the case. A 52-year-old woman presented to our institution with bilateral red eyes and associated decrease in vision. There was no significant ocular or medical history. However, she had received the influenza vaccination 1 month previously. There was no history of trauma, and the presence of tinnitus was noted on review of the systems. On ocular examination, her best-corrected visual acuities were 20/30 (right) and 20/100 (left). Intraocular pressure was 15 mmHg bilaterally. She never suffered from uveitis previously. The anterior chamber revealed 2+ cells in the both eyes. The fundus appearances demonstrated multifocal serous retinal detachments, which were further confirmed with optical coherence tomography [Fig. 1]. Fluorescein angiography showed multiple hyperfluorescent spots [Fig. 2]. Laboratory examination showed that both IgM and IgG of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and herpes simplex virus (HSV) were all negative in the serologic evaluation. Systemic steroid therapy was initiated promptly with intravenous methylprednisolone followed by systemic oral corticosteroids (1 mg/kg). Two months after treatment, anterior chamber got clear, and subretinal fluid disappeared. Her visual acuities were 20/20 (right) and 20/25 (left).
Figure 1

Fundus photographs showing bilateral multiple serous retinal detachments (a). Optical coherence tomography demonstrates serous retinal detachment in the both eyes (b)

Figure 2

Fluorescein angiography showing multiple hyperfluorescent spots

Fundus photographs showing bilateral multiple serous retinal detachments (a). Optical coherence tomography demonstrates serous retinal detachment in the both eyes (b) Fluorescein angiography showing multiple hyperfluorescent spots This case is unusual in its etiology and presentation, with the development of Vogt-Koyanagi-Harada Syndrome in a woman who had received the influenza vaccination 1 month previously and the presentation of the syndrome with bilateral serous retinal detachments. That the negative finding of IgM and IgG of CMV, EBV, and HSV in the serum of a patient, and the effective use of systemic use of steroid, strongly suggested that the mechanism of uveitis and serous retinal detachments of the patient should be an autoimmune response rather than infectious. We encourage ophthalmologists, rheumatologists, and uveitis specialists to consider influenza vaccine as a cause of Vogt-Koyanagi-Harada Syndrome if the vaccine has been recently administered.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  2 in total

1.  Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy.

Authors:  Micheal J Gallagher; Taygan Yilmaz; C Stephen Foster
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2009 May-Jun

2.  Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies.

Authors:  Nicola P Klein; Paula Ray; Diane Carpenter; John Hansen; Edwin Lewis; Bruce Fireman; Steven Black; Claudia Galindo; Johannes Schmidt; Roger Baxter
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

  2 in total
  5 in total

1.  Vogt-Koyanagi-Harada Disease Associated with Influenza A Virus Infection.

Authors:  Nozomu Yoshino; Ai Kawamura; Akira Ishii; Katsuyuki Yoshida; Tamami Watanabe; Takeshi Yamashita; Takahiko Fukuchi; Fumihiko Toyoda; Akihiko Kakehashi; Hitoshi Sugawara
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

Review 2.  Drug-induced uveitis: A review.

Authors:  Manisha Agarwal; Parthopratim Dutta Majumder; Kalpana Babu; Vinaya Kumar Konana; Mallika Goyal; Sara Touhami; Dinu Stanescu-Segall; Bahram Bodaghi
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

3.  Vogt-Koyanagi-Harada disease following influenza vaccination.

Authors:  Fahmeeda Murtaza; Austin Pereira; Mark S Mandelcorn; Alexander J Kaplan
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10

4.  Identification of differently expressed mRNAs by peripheral blood mononuclear cells in Vogt-Koyanagi-Harada disease.

Authors:  Yujing Li; Guannan Su; Fanfan Huang; Ying Zhu; Xiang Luo; Aize Kijlstra; Peizeng Yang
Journal:  Genes Dis       Date:  2021-06-30

5.  Ocular Adverse Events after Inactivated COVID-19 Vaccination in Xiamen.

Authors:  Xiuju Chen; Xiaoxin Li; Haibo Li; Minghan Li; Songjian Gong
Journal:  Vaccines (Basel)       Date:  2022-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.